Effect of native somatostatin on Sphincter of Oddi motility in patients with acute recurrent pancreatitis. A pilot study with Ultrasound-Secretin test

Digestive and Liver Disease

Volumn 38, Issue 4, 2006, Pages 268-271

  Di Francesco, V ^a   Angelini, G ^a   Zoico, E ^a   Zamboni, M ^a   Frulloni, L ^a   Cavallini, G ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Motility; Pancreatitis; Somatostatin; Sphincter of Oddi

Indexed keywords

SECRETIN; SODIUM CHLORIDE; SOMATOSTATIN;

ACUTE PANCREATITIS; ADULT; AGE DISTRIBUTION; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INFUSION; FEMALE; HUMAN; IDIOPATHIC DISEASE; INTESTINAL DYSMOTILITY; INTESTINE ENDOSCOPY; INTESTINE MOTILITY; MALE; MANOMETRY; ODDI SPHINCTER; PANCREAS DUCT; PANCREAS JUICE; PILOT STUDY; RECURRENT DISEASE; SEX DIFFERENCE; ULTRASOUND;

ACUTE DISEASE; ADOLESCENT; ADULT; FEMALE; GASTROINTESTINAL MOTILITY; HORMONES; HUMANS; MALE; MANOMETRY; PANCREATIC DUCTS; PANCREATITIS; PILOT PROJECTS; RECURRENCE; SECRETIN; SOMATOSTATIN; SPHINCTER OF ODDI;

EID: 33748482178     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2005.12.010     Document Type: Article

References (23)

1. Chiba T., and Yamada T. Gut somatostatin. In: Walsh J.H., and Dockray G.J. (Eds). Gut peptides (1994), Raven, New York 123-145
2. Cavallini G., and Frulloni L. Somatostatin and octreotide in acute pancreatitis: the never-ending story. Dig Liver Dis 33 (2001) 192-201
3. Poon R.T., Yeung C., Lo C.M., Yuen W.K., Liu C.L., and Fan S.T. Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc 49 (1999) 593-598
4. Andriulli A., Clemente R., Solmi L., Terruzzi V., Suriani R., Sigillito A., et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial. Gastrointest Endosc 56 (2002) 488-495
5. Binmoeller K.F., Harris A.G., Dumas R., Grimaldi C., and Delmont J.P. Does the somatostatin analogue octreotide protects against ERCP induced pancreatitis?. Gut 33 (1992) 1129-1133
6. Binmoeller K.F., Dumas R., Harris A.G., and Delmont J.P. Effect of somatostain analogue octreotide on human sphincter of Oddi. Dig Dis Sci 37 (1992) 773-777
7. Di Francesco V., Angelini G., Bovo P., Casarini M.B., Filippini M., Vaona B., et al. Effect of Octreotide on sphincter of Oddi motility in patients with acute recurrent pancreatitis. A manometric study. Dig Dis Sci 41 (1996) 2392-2396
8. Cavallini G., Rigo L., Brunori M.P., Moi A., Gaudio A., Di Francesco V., et al. Ultrasonography-secretin test pattern after acute administration of octreotide in healthy persons and in patients with recurrent acute pancreatitis. J Clin Gastroenterol 24 (1997) 231-234
9. Adami G.F., Leandri R., and Sales J.C. Effects of somatostatin on the rabbit Oddi's sphincter in vivo. Gastroenterol Clin Biol 10 (1986) 108-111
10. Huang J., Padbury R.T., Schloithe A.C., Cox M.R., Simula M.E., Harvey J.R., et al. Somatostatin stimulates the brush-tailed possum sphincter of Oddi in vitro and in vivo. Gastroenterology 115 (1998) 672-679
11. Lai K.H., Lo G.H., Cheng J.S., Fu M.T., Wang E.M., Chan H.H., et al. Effect of somatostatin on the sphincter of Oddi in patients with acute non-biliary pancreatitis. Gut 49 (2001) 843-846
12. Velosy B., Madacsy L., Szepes A., Pavics L., Csernay L., and Lonovics J. The effects of somatostatin and octreotide on the human sphincter of Oddi. Eur J Gastroenterol Hepatol 11 (1999) 897-901
13. Di Francesco V., Brunori M.P., Rigo L., Toouli J., Angelini G., Frulloni L., et al. Comparison of ultrasound-secretin test and sphincter of Oddi manometry in patients with recurrent acute pancreatitis. Dig Dis Sci 44 (1999) 336-340
14. Cavallini G., Rigo L., Brunori M.P., Moi A., Gaudio A., Di Francesco V., et al. Abnormal US response of main pancreatic duct after secretin stimulation in patients with acute pancreatitis of different etiology. J Clin Gastroenterol 18 (1994) 298-303
15. Viceconte G. Effects of ethanol on the sphincter of Oddi: an endoscopic manometric study. Gut 24 (1983) 20-27
16. Goff J.S. The effect of ethanol on the pancreatic duct sphincter of Oddi. Am J Gastroenterol 88 (1993) 656-660
17. Toouli J., Roberts-Thomson I.C., Kellow J., Dowsett J., Saccone G.T., Evans P., et al. Manometry based randomised trial of endoscopic sphincterotomy for sphincter of Oddi dysfunction. Gut 46 (2000) 98-102
18. Corazziari E. Sphincter of Oddi dysfunction. Dig Liver Dis 35 Suppl. 3 (2003) S26-S29 [review]
19. Testoni P.A., Lella F., Bagnolo F., Caporuscio S., Cattani L., Colombo E., et al. Long-term prophylactic administration of octreotide reduces the rise in serum amylase after endoscopic procedures on Vater's papilla. Pancreas 13 (1996) 61-65
20. Trendle M.C., Moertel C.G., and Kvols L.K. Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors. Cancer 79 (1997) 830-834
21. Neoptolemos J.P., Bailey I.S., and Carr-Locke D.L. Sphincter of Oddi dysfunction: results of treatment by endoscopic sphincterotomy. Br J Surg 75 (1988) 454-459
22. Toouli J., Roberts-Thomson I.C., Dent J., and Lee J. Sphincter of Oddi motility disorders in patients with idiopathic recurrent pancreatitis. Br J Surg 72 (1985) 859-863
23. Catalano M.F., Lahoti S., Alcocer E., Geenen J.E., and Hogan W.J. Dynamic imaging of the pancreas using real-time endoscopic ultrasonography with secretin stimulation. Gastrointest Endosc 48 (1998) 580-587